Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05577585
NA

Ketamine in OCD: Efficacy and Effects on Stress and Cognition

Sponsor: Medical University of Vienna

View on ClinicalTrials.gov

Summary

The main goal of this trial is to demonstrate therapeutic efficacy of low dose ketamine in patients with OCD. We expect that ketamine will alleviate symptoms in the hours following application, but also - if effective - that the anti-OCD effects might last for several days after a single infusion.

Official title: Ketamine Therapy in Obsessive-compulsive Disorder and Its Effects on Neuropsychological Function Under Stress in a Cross-over Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2022-10-01

Completion Date

2026-06

Last Updated

2025-06-25

Healthy Volunteers

No

Interventions

DRUG

Ketamine 50 MG/ML Blinded

See also Arm description

DRUG

Midazolam

See also Arm description

DRUG

Ketamine 50 MG/ML Open Label

Open Label Follow Up (up to 8 Infusions)

OTHER

Treatment as Usual (TAU)

Treatment as Usual may include psychotherapy, pharmacotherapy, physiotherapy, ergotherapy, or a combination of these-at the discretion of the treating physician, independently of the study.

Locations (1)

Medical University of Vienna, Department of Psychiatry and Psychotherapy

Vienna, Vienna, Austria